TENAX THERAPEUTICS, INC. Amortization of Debt Issuance Costs and Discounts
TENAX THERAPEUTICS, INC. (TENX) reported Amortization of Debt Issuance Costs and Discounts of $656.53 thousand for the 9-month period ending 2013-01-31, per its 10-Q filed 2013-03-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2013-03-18
- TENAX THERAPEUTICS, INC. amortization of debt issuance costs and discounts for the quarter ending 2013-01-31 was $0.00.
- TENAX THERAPEUTICS, INC. amortization of debt issuance costs and discounts for the quarter ending 2012-10-31 was $0.00.
- TENAX THERAPEUTICS, INC. amortization of debt issuance costs and discounts for the quarter ending 2012-07-31 was $656.53K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month |
|---|---|---|---|
| 2013-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-18 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | $656.53K 10-Q · filed 2013-03-18 |
| 2012-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-14 | $656.53K 10-Q · filed 2012-12-14 | |
| 2012-07-31 | $656.53K 10-Q · filed 2012-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |